High YKL-40 Serum Concentration Is Correlated with Prognosis of Chinese Patients with Breast Cancer

YKL-40 Protein Levels and Clinical Outcome of Human Endometrial Cancer

(2013) C Peng et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?

(2012) Xin-Qiang Xiao et al.   Hepatobiliary & Pancreatic Diseases International

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation and other cancer markers

(2011) R Shao et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Plasma YKL-40 levels in healthy subjects from the general population

(2011) Stig E. Bojesen et al.   CLINICA CHIMICA ACTA

Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma

(2011) Ralph A. Francescone et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers

(2011) M. Faibish et al.   MOLECULAR CANCER THERAPEUTICS

Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers

(2011) Paweł Stawerski et al.   PATHOLOGY RESEARCH AND PRACTICE

Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer

(2010) Ina Thöm et al.   CANCER

Plasma YKL-40: a potential new cancer biomarker?

(2009) Julia S Johansen et al.   Future Oncology

Overexpression of YKL-40 is an independent prognostic marker in gastric cancer

(2009) Jiong Bi et al.   HUMAN PATHOLOGY

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

(2009) R Shao et al.   ONCOGENE

Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer

(2008) Deniz Yamac et al.   ADVANCES IN THERAPY